KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Repligen (RGEN) Shares Outstanding (2016 - 2025)

Repligen (RGEN) has disclosed Shares Outstanding for 16 consecutive years, with $56.3 million as the latest value for Q4 2025.

  • On a quarterly basis, Shares Outstanding changed 0.42% to $56.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $56.3 million, a 0.42% change, with the full-year FY2025 number at $56.3 million, changed 0.42% from a year prior.
  • Shares Outstanding was $56.3 million for Q4 2025 at Repligen, roughly flat from $56.3 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $56.3 million in Q4 2025 to a low of $54.9 million in Q1 2021.
  • A 5-year average of $55.7 million and a median of $55.8 million in 2023 define the central range for Shares Outstanding.
  • Peak YoY movement for Shares Outstanding: grew 5.09% in 2021, then grew 0.28% in 2024.
  • Repligen's Shares Outstanding stood at $55.3 million in 2021, then rose by 0.43% to $55.6 million in 2022, then rose by 0.38% to $55.8 million in 2023, then increased by 0.58% to $56.1 million in 2024, then rose by 0.42% to $56.3 million in 2025.
  • Per Business Quant, the three most recent readings for RGEN's Shares Outstanding are $56.3 million (Q4 2025), $56.3 million (Q3 2025), and $56.3 million (Q2 2025).